| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 126.54B | 121.33B | 126.58B | 118.06B | 118.72B | 112.12B |
| Gross Profit | 14.09B | 14.53B | 13.49B | 13.48B | 12.34B | 12.78B |
| EBITDA | 7.77B | 5.79B | 7.32B | 7.70B | 6.80B | 7.66B |
| Net Income | 4.46B | 3.43B | 4.13B | 3.79B | 3.16B | 3.71B |
Balance Sheet | ||||||
| Total Assets | 76.03B | 88.50B | 90.72B | 92.89B | 87.18B | 84.69B |
| Cash, Cash Equivalents and Short-Term Investments | 10.55B | 13.91B | 12.31B | 14.23B | 10.00B | 11.65B |
| Total Debt | 787.00M | 4.63B | 6.68B | 2.10B | 2.80B | 2.13B |
| Total Liabilities | 23.99B | 33.44B | 33.79B | 36.82B | 34.47B | 34.22B |
| Stockholders Equity | 50.55B | 53.64B | 55.41B | 54.65B | 51.34B | 49.07B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 9.68B | -4.37B | 6.83B | -65.00M | 2.06B |
| Operating Cash Flow | 0.00 | 12.21B | -1.75B | 10.91B | 2.18B | 4.58B |
| Investing Cash Flow | 0.00 | -2.33B | -1.22B | -4.00B | -2.97B | -2.84B |
| Financing Cash Flow | 0.00 | -8.27B | 1.06B | -2.69B | -853.00M | -2.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥76.78B | 16.30 | ― | 0.99% | 21.37% | 44.91% | |
73 Outperform | ¥76.44B | 12.54 | ― | 1.25% | 4.37% | 6.30% | |
68 Neutral | ¥77.10B | 23.02 | ― | 8.02% | -4.15% | -16.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥69.31B | 15.25 | ― | 3.64% | 4.96% | 17.55% | |
63 Neutral | ¥81.42B | 19.52 | ― | 3.63% | 20.40% | 50.00% | |
58 Neutral | ¥74.02B | -149.33 | ― | 2.73% | -2.86% | 50.42% |